Source author record

Oliver Eales

Oliver Eales appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

Incorporating vaccine effects into epidemiological models: common pitfalls and solutions

Incorporating vaccination into mathematical models appears deceptively simple: models integrate vaccine-derived protections, such as reduced susceptibility to infection, using parameters informed by empirical estimates of vaccine efficacy or effectiveness (VE). In practice, however, empirical VE estimates often do not correspond directly to the parameters of epidemiological models. Here, we extend previous work to demonstrate that in order to accurately parameterize a model, one must consider both a vaccine's mechanism of action and the statistic used to infer VE from empirical data. When a vaccine confers leaky protection -- that is, vaccination partially rather than completely reduces individual infection risk -- we show that common empirical VE estimation methods do not provide directly applicable values for model parameters. Naive (i.e. direct) incorporation of these VE estimates into models results in an underestimate of population-level vaccine impact. To make progress when these estimates are the only available sources for VE, we introduce a parameterization approach which more accurately aligns the modeled effect of vaccination with empirical estimates. Under this adjusted parameterization approach, models predict fewer total infections and lower herd immunity thresholds for leaky vaccines than would be predicted under current parameterization practices. Our parameterization guidelines and adjustment approach can be used to improve accuracy in models that are used in vaccine decision making and public health planning.

preprint2019arXiv

Do bulges stop stars forming?

In this paper, we use the Herschel Reference Survey to make a direct test of the hypothesis that the growth of a stellar bulge leads to a reduction in the star-formation efficiency of a galaxy (or conversely a growth in the gas-depletion timescale) as a result of the stabilisation of the gaseous disk by the gravitational field of the bulge. We find a strong correlation between star-formation efficiency and specific star-formation rate in galaxies without prominent bulges and in galaxies of the same morphological type, showing that there must be some other process besides the growth of a bulge that reduces the star-formation efficiency in galaxies. However, we also find that galaxies with more prominent bulges (Hubble types E to Sab) do have significantly lower star-formation efficiencies than galaxies with later morphological types, which is at least consistent with the hypothesis that the growth of a bulge leads to the reduction in the star-formation efficiency. The answer to the question in the title is therefore, yes and no: bulges may reduce the star-formation efficiency in galaxies but there must also be some other process at work. We also find that there is a significant but small difference in the star-formation efficiencies of galaxies with and without bars, in the sense that galaxies with bars have slightly higher star-formation efficiencies.